Related references
Note: Only part of the references are listed.Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases? Data from a Long-Term Observation
Nasra Aboud et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2017)
New aspects on the efficacy of high-dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia
B. Mayer et al.
VOX SANGUINIS (2017)
Emerging drugs for immune thrombocytopenia (ITP)
Abdulgabar Salama
EXPERT OPINION ON EMERGING DRUGS (2017)
Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014
Rudolf Weide et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines
Maria Luisa Lozano et al.
ANNALS OF HEMATOLOGY (2016)
Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia
Matthieu Mahevas et al.
BLOOD (2016)
Multicenter Cohort Study Comparing US Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines
Char M. Witmer et al.
PEDIATRIC BLOOD & CANCER (2016)
The History of Cortisone Discovery and Development
Christopher M. Burns
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
Thrombopoietin Receptor Agonists Are Often Ineffective in Immune Thrombocytopenia and/or Cause Adverse Reactions: Results from One Hand
Fabian Depre et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
Current Management of Primary Immune Thrombocytopenia
Drew Provan et al.
ADVANCES IN THERAPY (2015)
Management of immune thrombocytopenia in adults: a population-based analysis of the French hospital discharge database from 2009 to 2012
Marc Michel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Can Immune Thrombocytopenia Be Cured with Medical Therapy?
Adam Cuker et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Immune Thrombocytopenia - Onkopedia guidelines update: Recommendations of a joint working group of the DGHO, OEGHO, SGH plus SSH and GPOH
Axel Matzdorff et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Mansoor N. Saleh et al.
BLOOD (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre
P. Y-I. Choi et al.
INTERNAL MEDICINE JOURNAL (2012)
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia
James B. Bussel et al.
BLOOD (2011)
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program
Mehdi Khellaf et al.
BLOOD (2011)
Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Mette Norgaard et al.
BLOOD (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region
Lee Lai Heng et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Advances in ITP - Therapy and Quality of Life - A Patient Survey
Axel C. Matzdorff et al.
PLOS ONE (2011)
Current treatment options for primary immune thrombocytopenia
Abdulgabar Salama
EXPERT REVIEW OF HEMATOLOGY (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Treatment practices in adults with chronic immune thrombocytopenia - a European perspective
Francesco Rodeghiero et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag
Jyoti D. Chouhan et al.
PHARMACOTHERAPY (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Subcutaneous Anti-D Treatment of Idiopathic Thrombocytopenic Purpura in Children
Mimi Kjaersgaard et al.
PEDIATRIC BLOOD & CANCER (2009)
Refractory immune thrombocytopenic purpura: current strategies for investigation and management
Bethan Psaila et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Immune thrombocytopenic purpura in adults
Bertrand Godeau et al.
CURRENT OPINION IN HEMATOLOGY (2007)
Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia
O. Meyer et al.
PEDIATRIC BLOOD & CANCER (2006)
Management of patients with refractory immune thrombocytopenic purpura
J. . N. George
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy - A systematic review
SK Vesely et al.
ANNALS OF INTERNAL MEDICINE (2004)
Efficacy and safety of anti-D given by subcutaneous injection to patients with autoimmune thrombocytopenia
O Meyer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
JEA Portielje et al.
BLOOD (2001)